GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArcticZymes Technologies ASA (FRA:B4V) » Definitions » Cyclically Adjusted Revenue per Share

ArcticZymes Technologies ASA (FRA:B4V) Cyclically Adjusted Revenue per Share : €0.17 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is ArcticZymes Technologies ASA Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

ArcticZymes Technologies ASA's adjusted revenue per share for the three months ended in Mar. 2024 was €0.049. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €0.17 for the trailing ten years ended in Mar. 2024.

During the past 12 months, ArcticZymes Technologies ASA's average Cyclically Adjusted Revenue Growth Rate was 12.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 16.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 11.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of ArcticZymes Technologies ASA was 16.30% per year. The lowest was 4.60% per year. And the median was 10.70% per year.

As of today (2024-06-08), ArcticZymes Technologies ASA's current stock price is €2.145. ArcticZymes Technologies ASA's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €0.17. ArcticZymes Technologies ASA's Cyclically Adjusted PS Ratio of today is 12.62.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of ArcticZymes Technologies ASA was 78.31. The lowest was 2.98. And the median was 20.38.


ArcticZymes Technologies ASA Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for ArcticZymes Technologies ASA's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ArcticZymes Technologies ASA Cyclically Adjusted Revenue per Share Chart

ArcticZymes Technologies ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.12 0.12 0.14 0.17 0.17

ArcticZymes Technologies ASA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.16 0.17 0.17 0.17

Competitive Comparison of ArcticZymes Technologies ASA's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, ArcticZymes Technologies ASA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ArcticZymes Technologies ASA's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ArcticZymes Technologies ASA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where ArcticZymes Technologies ASA's Cyclically Adjusted PS Ratio falls into.



ArcticZymes Technologies ASA Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ArcticZymes Technologies ASA's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.049/132.6000*132.6000
=0.049

Current CPI (Mar. 2024) = 132.6000.

ArcticZymes Technologies ASA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.028 97.500 0.038
201409 0.026 98.500 0.035
201412 0.027 98.600 0.036
201503 0.031 99.200 0.041
201506 0.030 100.100 0.040
201509 0.041 100.600 0.054
201512 0.030 100.900 0.039
201603 0.043 102.500 0.056
201606 0.044 103.800 0.056
201609 0.055 104.200 0.070
201612 0.028 104.400 0.036
201703 0.048 105.000 0.061
201706 0.044 105.800 0.055
201709 0.039 105.900 0.049
201712 0.027 106.100 0.034
201803 0.038 107.300 0.047
201806 0.026 108.500 0.032
201809 0.061 109.500 0.074
201812 0.041 109.800 0.050
201903 0.034 110.400 0.041
201906 0.041 110.600 0.049
201909 0.050 111.100 0.060
201912 -0.026 111.300 -0.031
202003 0.035 111.200 0.042
202006 0.065 112.100 0.077
202009 0.037 112.900 0.043
202012 0.038 112.900 0.045
202103 0.083 114.600 0.096
202106 0.042 115.300 0.048
202109 0.048 117.500 0.054
202112 0.078 118.900 0.087
202203 0.097 119.800 0.107
202206 0.057 122.600 0.062
202209 0.058 125.600 0.061
202212 0.052 125.900 0.055
202303 0.055 127.600 0.057
202306 0.047 130.400 0.048
202309 0.054 129.800 0.055
202312 0.048 131.900 0.048
202403 0.049 132.600 0.049

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


ArcticZymes Technologies ASA  (FRA:B4V) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

ArcticZymes Technologies ASA's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2.145/0.17
=12.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of ArcticZymes Technologies ASA was 78.31. The lowest was 2.98. And the median was 20.38.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


ArcticZymes Technologies ASA Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of ArcticZymes Technologies ASA's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


ArcticZymes Technologies ASA (FRA:B4V) Business Description

Industry
Traded in Other Exchanges
Address
Sykehusveien 23, Tromso, NOR, N-9294
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments that are Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA.

ArcticZymes Technologies ASA (FRA:B4V) Headlines

No Headlines